SynthesisOncotarget2016

Incidence and relative risk of hemorrhagic events associated with ramucirumab in cancer patients: a systematic review and meta-analysis.

Rui Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.